The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Backgound: Sulphadoxine/sulphalene-pyrimethamine (SP) was adopted in Kenya as first line therapeutic for uncomplicated malaria in 1998. By the second half of 2003, there was convincing evidence that SP was failing and had to be replaced. Despite several descriptive investigations of policy change an...
Үндсэн зохиолчид: | Amin, A, Zurovac, D, Kangwana, B, Greeenfield, J, Otieno, D, Akhwale, W, Snow, R |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
BioMed Central
2007
|
Нөхцлүүд: |
Ижил төстэй зүйлс
-
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.
-н: Amin, A, зэрэг
Хэвлэсэн: (2007) -
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
-н: Otieno Dorothy N, зэрэг
Хэвлэсэн: (2007-05-01) -
The decline in paediatric malaria admissions on the coast of Kenya
-н: Okiro, E, зэрэг
Хэвлэсэн: (2007) -
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
-н: Zurovac, D, зэрэг
Хэвлэсэн: (2007) -
Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine
-н: Wasunna, B, зэрэг
Хэвлэсэн: (2008)